Ronkonkoma, NY, USA, October 1, 2020 - ISO 80369-7, which specifies dimensions and requirements for the design and performance of small-bore connectors intended to be used in intravascular or hypodermic applications, is currently under revision. Publication is estimated to occur by year-end 2020.
Qosina stocks nearly 100 compliant components that meet the guidelines as stated in ISO 594-1/2 and ISO 80369-7, which are the current consensus standards. To view a full listing of our compliant products, please visit https://www.qosina.com/iso-80369-7.
As a medical component supplier, Qosina makes it a priority to stay abreast of regulatory changes and safety standards in the industry, and provide customers with solutions to achieve compliance, minimize patient risk and be innovative when designing devices. We will continue to closely monitor the new ISO 80369-7 publication date and release updates as they are received.
Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time to market by providing thousands of stock components. The company’s vast catalog features more than 5,000 products shown in full-scale illustrations on a one-centimeter grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 13485, ISO 9001, ISO 22301 and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO Class 8 Clean Room. To learn about Qosina’s full component offering, which includes the newest products, visit www.qosina.com or call +1 (631) 242-3000. Visit Qosmedix, Qosina's cosmetics division, at www.qosmedix.com. Qosmedix is a certified global supplier of beauty supplies to the cosmetic, skincare, spa and salon industries.